Unrestrained chronic mTOR activation may be responsible for sustaining metabolic and mitochondrial dysfunction in AD, driving the breakdown of the BBB via endothelial cell dysfunction, as well as driving the hyperphosphorylation of tau, and formation of amyloid plaques in the brain (Mueed et al., 2018). This evidence concerns the gene MAPT and Alzheimer disease.